Pelagos is developing a new class of therapeutics called “exercise mimetics” that activate the same metabolic, mitochondrial and structure-function pathways observed with the beneficial effects of aerobic exercise. We believe this new innovative concept can address some of society’s most costly diseases of an aging population, but also one that is becoming more sedentary.
